Xtx Topco LTD Virios Therapeutics, Inc. Transaction History

Xtx Topco LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$0.18 - $0.58 $7,677 - $24,737	42,650 New	42,650 $9,000
Q4 2023 Feb 13, 2024	BUY	$0.46 - $0.9 $3,826 - $7,487	8,319 Added 57.61%	22,760 $12,000
Q3 2023 Nov 13, 2023	SELL	$0.86 - $2.42 $1,713 - $4,823	-1,993 Reduced 12.13%	14,441 $13,000
Q2 2023 Aug 14, 2023	BUY	$0.35 - $1.94 $5,751 - $31,881	16,434 New	16,434 $22,000

1.12M

Ticker VIRI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 18,330,400
Market Cap $81.4M
Description
Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.